Eric Quemeneur

Company: Transgene

Job title: Chief Scientific Officer

Seminars:

Evaluating the Engineering Challenges & Strategies for Novel Viral Platforms to Overcome These Hurdles & Streamline Your OV Candidates into the Clinics 9:30 am

Adapting viral genomes for enhanced tumor targeting and replication Overcoming limitations in viral tropism and immune evasion Assessing potential off-target effects and toxicity of novel viral platforms Designing and optimizing viral modifications to minimize non-specific tissue damage Predictive toxicology and risk assessment approaches for early safety evaluationRead more

day: Day One